Chemokine/cytokine profiling after rituximab: reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS. [electronic resource]
Producer: 20110722Description: 384-9 p. digitalISSN:- 1096-0023
- Adrenocorticotropic Hormone -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- B-Cell Activating Factor -- blood
- B-Lymphocytes -- drug effects
- Chemokine CXCL13 -- blood
- Chemokines -- blood
- Child
- Cytokines -- blood
- Drug Administration Schedule
- Drug Therapy, Combination
- Enzyme-Linked Immunosorbent Assay
- Humans
- Immunoassay -- methods
- Immunoglobulins, Intravenous -- administration & dosage
- Immunologic Factors -- administration & dosage
- Opsoclonus-Myoclonus Syndrome -- blood
- Rituximab
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.